<!DOCTYPE html>
<html>
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<meta name="viewport"content="target-densitydpi=device-dpi, initial-scale=1.0,user-scalable=no"/>
	<link rel="stylesheet" type="text/css" href="../assets/css/style.css"/>
	<link rel="stylesheet" type="text/css" href="../assets/css/estilos.css"/>
	<link rel="stylesheet" type="text/css" href="../assets/css/flaticon.css"/>
	<script type="text/javascript" src="../assets/js/jquery.js"></script>
	<script type="text/javascript" src="../assets/js/functions.js"></script>
</head>
<body>
	<div id="contenedor">
		<div id="menu_slide">
			<div id="as" class="fonts_i"><i class="flaticon-text162"></i></div>
			<div class="fonts_i"><input type="range" id="slide" min="0" max="72" value="0"></div>
			<div id="am" class="fonts_i"><i class="flaticon-edit-text"></i></div>
		</div>
		<div id="btn_opciones"><i class="flaticon-font14 fonts"></i></div>
		<div id="menu_botones">
			<div class="menu_contenedor">
				<div id="btn_normal" class="botones-caja-lector"></div>
				<div id="btn_sepia" class="botones-caja-lector"></div>
				<div id="btn_noche" class="botones-caja-lector"></div>
			</div>
			<div class="menu_contenedor">
				<select id="select_font">
					<option value="arial">Arial</option>
					<option value="century">New Century</option>
					<option value="futura">Futura</option>
					<option value="gillsans">Gill Sans</option>
					<option value="RobotoLight">Roboto</option>
					<option value="timesNew">Times New Roman</option>
				</select>
			</div>
		</div>
		<div id="contenedor-texto">
			<h1 id="subtitulo">3. Pathophysiology</h1>
			<p>
				Diabetic foot is a neuropathy-based disorder induced by sustained hyperglycemia that, with or without concomitant ischemia and after a traumatic trigger, eventually generates a foot injury or ulcer.<sup>5</sup>
    			<br>
    			<br>
    			The three cornerstones in the pathophysiology of diabetic foot are:
			    <ul>
			      <li>Neuropathy<sup>5</sup> </li>
			      <li>Ischemia<sup>5</sup> </li>
			      <li>Infection<sup>5</sup></li>
			    </ul>
			    <p>
					<b>a. Diabetic neuropathy</b>
					<br>
					Diabetic neuropathy can be present in up to 50% of diabetics over 60 years.<sup>4</sup>
					<br>
					<br>
					<b>Distal symmetric polyneuropathy (DSP)</b> is the most common form of diabetic neuropathy.<sup>6</sup> DSP involves motor and sensory fibers, thereby altering sensory, motor and autonomic functions.<sup>6</sup>
					<br>
					<br>
					The main clinical manifestation of DSP is sensory loss.<sup>7</sup>
					<br>
					<br>
					<b>Sensory neuropathy </b>is established as the cause of injuries through external trauma (burn produced by a hot-water bottle, wound when walking barefoot, inappropriate footwear that exerts pressure, etc.) that is not perceived by the patient due to alterations of the protective sensation.<sup>4</sup>
					<br>
					<br>
					<b>Motor neuropathy </b> is responsible for internal trauma, which encompasses the acquired deformities of the feet and alterations in plantar pressure (plantar overpressure, claw toes or hammertoes, hallux, plantar hyperkeratosis, etc.).<sup>4</sup>
					<br>
					<br>
					<b>Autonomic neuropathy </b> facilitates fissure formation and entry of germs that may lead to infection.<sup>5</sup>
					<br>
					<br>
					<b>b. Ischemia</b>
					<br>
					<br>
					<b>Microcirculation</b>
					<br>
					The role of microcirculation in ulcer genesis and wound healing in diabetic patients is controversial.<sup>8</sup>
					<br>
					<br>
					<b>Peripheral arterial disease (PAD)</b>
					Peripheral arterial disease (secondary to atherosclerosis) is a common condition in patients with diabetes.<sup>9</sup><br />
					The annual incidence of PAD for patients with type 1 diabetes is 5,5/1000 patients, and 13,6/1000 for patients with type 2 diabetes.<sup>9</sup>
					<br>
					Atherosclerosis in diabetic patients tends to occur at younger ages. It is usually more widespread and affect distal vessels.<sup>9</sup>
					<br>
					<br>
					In diabetic patients, the risk of ulceration and amputation increases in the presence of peripheral arterial disease.<sup>9</sup> Patients with diabetes have 2 to 4 times higher rates of peripheral arterial disease.<sup>10</sup> In diabetic
					population, infrapopliteal arterial occlusive disease is more common.<sup>10</sup>
					<br>
					<br>
					<b>c. Infection</b>
					<br>
					In diabetic patients, inflammatory response disturbances have been described, especially in:</p>
					<ul>
						<li>Diapedesis mechanisms<sup>5</sup></li>
						<li>Leukocyte adhesion<sup>5</sup></li>
						<li>Chemotaxis<sup>5</sup></li>
						<li>Destructive capacity of polymorphonuclear cells<sup>5</sup></li>
					</ul>
					<p>
						The three phases of the inflammatory response (increased blood supply, hyperproteic exudate accumulation and collagen formation) may be altered in the diabetic patient.<sup>5</sup>
						<br>
						<br>
						The decrease in blood supply, which causes hypoxia, and alterations in the vascular response promote the growth of anaerobic bacteria and modify the local self-regulatory mechanisms.<sup>5</sup>
					</p>
				</p>      
			</p>
		</div>
	</div>
</body>
</html>